Welcome to our dedicated page for Walgreen Boots news (Ticker: WBA), a resource for investors and traders seeking the latest updates and insights on Walgreen Boots stock.
This page provides a focused view of news and announcements historically associated with Walgreens Boots Alliance, Inc. (formerly Nasdaq: WBA) and its related businesses, including Walgreens and Walgreens Specialty Pharmacy. Company communications highlight Walgreens as a U.S. retail pharmacy brand founded in 1901 that serves nearly 9 million customers and patients each day across approximately 8,500 stores in the U.S. and Puerto Rico, and Walgreens Boots Alliance as a pharmacy-led health and wellbeing enterprise formed through the combination of Walgreens and Alliance Boots.
News related to WBA and Walgreens has covered several key themes. One major area is corporate transactions and capital markets activity. In 2025, a series of announcements detailed the Agreement and Plan of Merger under which Blazing Star Merger Sub, Inc. merged with and into Walgreens Boots Alliance, Inc., resulting in the company becoming a wholly owned subsidiary of Blazing Star Parent, LLC, an affiliate of Sycamore Partners. Related releases described tender offers and consent solicitations for various series of Walgreens Boots Alliance and Walgreen Co. notes, pricing terms, extensions of expiration times and settlement dates, and the final results of these offers.
Another important news category involves the company’s transition from public to private ownership. A Form 8-K filed on August 28, 2025 describes the completion of the merger, the cash consideration and divested asset proceed rights received by shareholders, and the cessation of trading of WBA common stock and certain notes on Nasdaq. A subsequent Form 25 documents the removal of these securities from listing, and a Form 15 filed on September 8, 2025 terminates registration and suspends reporting obligations. Sycamore Partners separately announced the completion of its acquisition of Walgreens Boots Alliance, Inc. and its intention that Walgreens, The Boots Group, Shields Health Solutions, CareCentrix and VillageMD operate as standalone companies under private ownership.
Operational and healthcare-focused news also features prominently. Walgreens Specialty Pharmacy announced an expansion of its limited distribution drug network to 265 products, emphasizing its role in specialty medications for patients with rare, complex and chronic diseases and its independence from pharmacy benefit managers. Walgreens has also issued releases on vaccination services, including nationwide flu shot availability for individuals three years and older, walk-in and scheduled appointments, digital check-in features and incentives for myWalgreens members receiving vaccines.
Investors and observers using this news page can review historical coverage of WBA’s merger process, debt tender offers, governance and shareholder actions, as well as Walgreens’ specialty pharmacy initiatives and vaccination programs. For those tracking the evolution of the company, these articles collectively document WBA’s path from a publicly traded integrated healthcare and retail group to a privately held organization under Sycamore Partners, while also illustrating how Walgreens positions its pharmacies and specialty operations within the broader healthcare landscape.
Uber Eats has launched nationwide acceptance of SNAP EBT payments, partnering with Albertsons Companies' grocery stores (including Safeway, Jewel-Osco, and Vons) and Walgreens locations. The initiative aims to expand access to nutritious food for millions of Americans. EBT cardholders will receive free delivery on their first three SNAP-eligible orders and a 3-month free Uber One membership. The service, powered by Forage's payment technology, allows eligible customers to order groceries through the Uber Eats app using their SNAP benefits. Uber plans to add more retailers to the program in the coming months.
Walgreens Boots Alliance (WBA) has announced its board of directors' declaration of a quarterly dividend of 25 cents per share, maintaining the same rate as the previous quarter. The dividend will be paid on December 12, 2024, to stockholders of record as of November 18, 2024. This continues the company's remarkable dividend payment streak, which spans 368 consecutive quarters (92 years), including payments from its predecessor company, Walgreen Co.
Walgreens (Nasdaq: WBA) and Veeva Systems (NYSE: VEEV) have announced a long-term strategic partnership aimed at improving patient outcomes in the healthcare sector. The collaboration will enhance Veeva Data Cloud products while granting Walgreens access to Veeva's Data Cloud and Clinical Platform.
As a major retail and specialty pharmacy provider, Walgreens will contribute to expanding the breadth of data in Veeva Data Cloud, enabling life sciences companies to better understand market trends and improve patient care. This partnership leverages Walgreens' position as a neighborhood health destination and Veeva's expertise in life sciences software and data services.
Walgreens and Dion's Chicago Dream have partnered to install a Dream Vault smart locker at the Walgreens store in Gage Park, Chicago. This initiative aims to provide free, high-quality produce to over 175 local households weekly, expanding their reach to a total of 275 Chicagoland households-in-need.
The Dream Vault, unveiled last year, is designed to serve up to 200 households within a one-mile radius, offering a week's supply of fresh fruits and vegetables at no cost. This collaboration addresses food insecurity in Gage Park, where nearly 21% of residents lack reliable access to healthy food.
Walgreens' involvement includes sponsoring Dream Deliveries for 100 households and now hosting the Dream Vault. The initiative aligns with Walgreens' commitment to improving health equity and providing essential services to the community for almost 125 years.
Walgreens is urging the public to participate in National Prescription Drug Takeback Day on October 26th, 2024, as part of its ongoing efforts to combat prescription drug abuse. The company has collected and properly disposed of over 6 million pounds of unused prescription medications since 2016 through its safe medication disposal program.
Walgreens offers more than 1,550 kiosks across 46 states and Washington, D.C. for year-round, no-cost disposal of unwanted, unused, or expired medications. Customers can locate these kiosks using the store locator on walgreens.com. Pharmacies without kiosks provide free DisposeRx or other disposal options upon request. All collected medications are safely incinerated at DEA-registered facilities.
Walgreens Boots Alliance (WBA) reported fiscal year 2024 earnings, with fourth quarter results in line with expectations. Key points include:
- Q4 loss per share of $3.48, adjusted EPS of $0.39 (down 40.8% on constant currency)
- Q4 sales increased 6.0% year-over-year to $37.5 billion
- Fiscal 2024 loss per share of $10.01, adjusted EPS of $2.88 (down 27.9% on constant currency)
- Fiscal 2024 sales increased 6.2% to $147.7 billion
- Achieved U.S. Healthcare segment adjusted EBITDA increase of $442 million in fiscal 2024
- Announced footprint optimization program targeting approximately 1,200 store closures over three years
- Fiscal 2025 guidance: adjusted EPS of $1.40 to $1.80
Walgreens has appointed Jason Stenta as SVP and Chief Commercial Officer, effective early October. In this new role, Stenta will lead the company's B2B commercial growth strategy, focusing on developing and commercializing healthcare services based on Walgreens' core assets. He will also work on enhancing partnerships with payers, health system providers, and life sciences companies.
Stenta brings nearly 20 years of healthcare experience, most recently serving as SVP of payer sales at Optum, a UnitedHealth Group company. Prior to that, he held leadership roles at CVS Health for 10 years. His appointment is expected to strengthen Walgreens' position as a leading community pharmacy and health services provider in the U.S.
Mary Langowski, EVP and president of U.S. Healthcare at Walgreens Boots Alliance, expressed confidence in Stenta's strategic and relationship-driven leadership, highlighting his experience with complex healthcare organizations and understanding of market dynamics, regulatory requirements, and customer needs.
Walgreens announces the launch of the Student Loan 401(k) Match Program, set to begin in January 2025. This innovative benefit allows eligible team members to qualify for company 401(k) match contributions while paying down their student loans. The program aims to address the financial burden of student debt, particularly among pharmacy team members, where over half face educational debt.
Key features of the program include:
- Matching eligible student loan payments up to 4% of eligible pay
- Eligibility generally after one year plus 1,000 hours of service
- Enhanced Pharmacy Educational Assistance Program (PEAP) offering up to $40,000 in tuition assistance
This initiative reflects Walgreens' commitment to supporting team members' financial well-being and career growth, positioning the company as a leader among large employers in addressing student loan debt.
Walgreens (WBA) has announced that it will close most of its stores and pharmacies on Thanksgiving Day (November 28) for the second consecutive year. This decision aims to give team members more time with their loved ones. However, 500 Walgreens 24-hour locations and 300 pharmacies within those locations will remain open to meet customer healthcare needs. The company received positive feedback from employees about last year's Thanksgiving closure and decided to continue the tradition.
Walgreens emphasizes that team members working at 24-hour locations on Thanksgiving are essential for delivering care, especially during respiratory illness season. The company will maintain regular hours on November 27 and 28, and all locations will be open on Christmas Day and New Year's Day. Customers are advised to check local store and pharmacy hours using the Walgreens store locator.
Walgreens (WBA) has joined Pulse by NABP™, a digital platform designed to enhance visibility in the drug supply chain and protect patients from counterfeit medications. This move will assist Walgreens with Drug Supply Chain Security Act (DSCSA) compliance and ensure its prescription medication suppliers are properly licensed.
The DSCSA, enacted in 2013, aims to improve pharmaceutical supply chain safety and prevent harmful drugs from entering the market. Pulse will help Walgreens verify that only legitimate and authorized trading partners provide medications to its patients.
John Colaizzi, VP of pharmacy practice at Walgreens, emphasized the company's commitment to patient safety. NABP is initially rolling out Pulse to select supply chain users, with plans to offer free registration to all prescription drug supply chain members to facilitate DSCSA-required interoperability.
FAQ
What is the current stock price of Walgreen Boots (WBA)?
What is the market cap of Walgreen Boots (WBA)?
